NVOS - Novo Integrated Price Target Chart

Novo Integrated Sciences (NVOS) is an IT holding company that integrates rehabilitation and digital technologies through an AI-powered hybrid care system. The business's environmental focus is based on the digitalization of documentation, which minimizes paper usage. Operating profit currently stands at 0.00 while management stabilizes assets. This chart illustrates the market price of the company.

NVOS Novo Integrated Sciences, Inc. Price Target Chart (07/04/2022 - 11/16/2024)

Metric breakdowns and analytics for Novo Integrated (NVOS)

- stock price and consensus target price:

Share Price novointegrated.com|NVOS - Consensus Target

- market capitalization statistics:

Market Value Novo Integrated|NVOS - Total Company Value

- issuer book value statistics:

Net Asset Value per Share Novo Integrated Sciences|NVOS - Company Book Value|Market Capitalization to Book Value novointegrated.com|NVOS - Cumulative Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Capital Novo Integrated Sciences|NVOS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Novo Integrated Sciences Corp|NVOS - Company Aggregate Debts|Debts to Book Value Novo Integrated|NVOS - Company Long-Term Debts|Company Short-Term Debts Novo Integrated Sciences|Intermediate Liquidity Ratio novointegrated.com

- earnings and multiples data:

NVOS - Company Net Income|Future Profit Novo Integrated Sciences|NVOS - P/E Multiple|Projected Price to Earnings Ratio Novo Integrated Sciences Inc|NVOS - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Novo Integrated|NVOS - Operating profit before deduction of amortization|Earnings per share for the last four quarters Novo Integrated Sciences|NVOS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months novointegrated.com|NVOS - Earnings per share growth in current year|Expected net earnings per share growth next year Novo Integrated Sciences

General company analysis:NVOS - novointegrated.com

The consensus forecast aggregates average expert estimates of the asset's fair value, allowing investors to filter out market volatility and assess fundamental growth potential. The price action of the average target price reflects market confidence in the Novo Integrated Sciences (NVOS) strategy to build a decentralized medtech ecosystem through a series of acquisitions, where sharp fluctuations in the indicator signal high risks associated with the expansion phase.

Competing companies